Drug stocks sluggish, but Aastrom soars By: MarketWatch March 28, 2011 at 10:19 AM EDT Drug-sector benchmarks start out the trading week on a flat note, but shares of stem-cell researcher Aastrom soared on a buy rating from Stifel Nicolaus. Read More >> Related Stocks: Quest Diagnostics